Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21)
| קרן | National Cancer Institute/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 17/11/2020 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The purpose of this grant is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions Initiative.
PQ1: What are the underlying causes of the unexplained rising incidence in early-onset cancers? PQ2: How does intermittent fasting affect cancer incidence, treatment response, or outcome? PQ3: How do selective pressures affect cell competition and cooperation during cancer initiation and development? PQ4: What mechanisms explain sex differences in cancer incidence, lesion location, or response to therapy? PQ5: What strategies can block or reverse the emergence of new cell lineage states induced by cancer treatments? PQ6: How can cancer cachexia be reversed? PQ7: What methods can be developed to integrate patient-generated health data into electronic health records? PQ8: What strategies improve and sustain coordination of comprehensive healthcare for underserved cancer patients with comorbidities? PQ9: What methods can be developed to effectively study small or rare populations relevant to cancer research?
Funding: $275,000 total Duration: 2 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due dates: 30.3.20, 17.10.20 Full proposal due dates: 30.4.20, 17.11.20
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 19/01/2020 |
